Raised MCP-4 levels in symptomatic carotid atherosclerosis: An inflammatory link between platelet and monocyte activation

Cardiovascular Research

Volumn 86, Issue 2, 2010, Pages 265-273

  Breland, Unni M ^a,c   Michelsen, Annika E ^a   Skjelland, Mona ^a   Folkersen, Lasse ^d   Krohg Sørensen, Kirsten ^a   Russell, David ^a,c   Ueland, Thor ^a,c   Yndestad, Arne ^a   Paulsson Berne, Gabrielle ^d   Dams, Jan K ^a,b   Øie, Erik ^a   Hansson, Gøran K ^d   Halvorsen, Bente ^a,c   Aukrust, Pl ^a,b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Inflammation; Monocytes; Platelets

Indexed keywords

CHEMOKINE RECEPTOR CCR2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 4; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION;

AGED; AGED, 80 AND OVER; CAROTID STENOSIS; CASE-CONTROL STUDIES; CELL LINE; CHEMOKINE CCL5; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-8; MALE; MIDDLE AGED; MONOCYTE CHEMOATTRACTANT PROTEINS; MONOCYTES; PLATELET ACTIVATION; RECEPTORS, CCR2; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 77951684315     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq044     Document Type: Article

References (26)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
2. Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 2008;28:1897-1908.
3. Aukrust P, Halvorsen B, Yndestad A, Ueland T, Øie E, Otterdal K et al. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 2008;28:1909-1919.
4. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P et al. Absence of mono-cyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-281. (Pubitemid 128373654)
5. 2/2 mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998;394: 894-897. (Pubitemid 28410911)
6. Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 1998;101:353-363. (Pubitemid 28067332)
7. Galkina E, Harry BL, Ludwig A, Liehn EA, Sanders JM, Bruce A et al. CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall. Circulation 2007;116:1801-1811. (Pubitemid 350287105)
8. Combadiere C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ et al. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 2003;107:1009-1016. (Pubitemid 36258725)
9. Combadière C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008; 117:1649-1657. (Pubitemid 351482605)
10. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002;38:881-885. (Pubitemid 34496945)
11. Iwamoto T, Okamoto H, Iikuni N, Takeuchi M, Toyama Y, Tomatsu T et al. Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis. Rheumatology 2006;45:421-424.
12. Skjelland M, Michelsen AE, Krohg-Sørensen K, Tennøe B, Dahl A, Bakke S et al. Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity. Atherosclerosis 2007;195:e142-e146. (Pubitemid 350087972)
13. Olofsson PS, Söderström LA, Jern C, Sirsjö A, Ria M, Sundler E et al. Genetic variants of TNFSF4 and risk for carotid artery disease and stroke. J Mol Med 2009;87: 337-346.
14. Otterdal K, Smith C, Øie E, Pedersen TM, Yndestad A, Stang E et al. Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes. Blood 2006;108:928-935. (Pubitemid 44154627)
15. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab 2002;3:175-187. (Pubitemid 34326529)
16. Hansson GK, Robertson AK, Söderberg-Nauclér C. Inflammation and atherosclerosis. Annu Rev Pathol 2006;1:297-329.
17. Bra°nén L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2004;24:2137-2142. (Pubitemid 39482442)
18. Erbel C, Sato K, Meyer FB, Kopecky SL, Frye RL, Goronzy JJ et al. Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol 2007;102: 123-132. (Pubitemid 46189953)
19. Rus HG, Niculescu F, Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1991;89:247-254.
20. Ardigo D, Assimes TL, Fortmann SP, Go AS, Hlatky M, Hytopoulos E et al. Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics 2007;31:402-409. (Pubitemid 350127780)
21. Berkhout TA, Sarau HM, Moores K, White JR, Elshourbagy N, Appelbaum E et al. Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B. J Biol Chem 1997;272: 16404-16413. (Pubitemid 27276466)
22. Wæhre T, Yndestad A, Smith C, Haug T, Haugen Tunheim SH, Gullestad L et al. Increased expression of interleukin 1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors. Circulation 2004;109:1966-1972. (Pubitemid 38544487)
23. Weber C. Platelets and chemokines in atherosclerosis: partners in crime. Circ Res 2005;96:612-616. (Pubitemid 40478327)
24. Kraaijeveld AO, de Jager SC, de Jager WJ, Prakken BJ, McColl SR, Haspels I et al. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Circulation 2007;116:1931-1941. (Pubitemid 350287089)
25. von Hundelshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001;103:1772-1777. (Pubitemid 32291415)
26. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 2009;15:97-103.